Title : Pharmacokinetics of Rytary®, An Extended-Release Capsule Formulation of Carbidopa-Levodopa.

Pub. Date : 2017 Sep

PMID : 28236251






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 A new extended-release (ER) carbidopa-levodopa capsule product (also referred to as IPX066) was developed and approved in the US as Rytary and in the EU as Numient . Levodopa epiregulin Homo sapiens
2 Phase III studies of this ER carbidopa-levodopa capsule formulation in patients with PD have shown a significant reduction in "off" time compared with IR carbidopa-levodopa and carbidopa-levodopa-entacapone. Levodopa epiregulin Homo sapiens
3 We present a review of the clinical pharmacokinetics and pharmacodynamics of this ER product of carbidopa-levodopa in healthy subjects and in patients with PD. Levodopa epiregulin Homo sapiens